Profound Medical Corp. (PROF)

Profound Medical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	41.18	26.21	46.52	67.15	83.91	14.8
Cash & Cash Equivalents	41.18	26.21	46.52	67.15	83.91	14.8
Cash Growth	-4.20%	-43.65%	-30.73%	-19.97%	466.98%	-51.77%
Receivables	6.51	7.29	6.34	5.03	7.43	3.13
Inventory	6.98	6.99	7.94	7.41	5.33	3.67
Other Current Assets	0.88	1.41	1.22	-2.47	1.07	1.21
Total Current Assets	55.54	41.9	62.02	77.13	97.74	22.81
Property, Plant & Equipment	1.41	1.53	1.72	1.9	2.28	2.22
Goodwill and Intangibles	0.43	0.49	0.68	4.12	4.58	5.03
Other Long-Term Assets	0	0	0	3.62	0	0
Total Long-Term Assets	1.84	2.02	2.4	9.65	6.86	7.25
Total Assets	57.38	43.91	64.42	86.78	104.6	30.06
Accounts Payable	2.88	3.28	2.03	3.18	3.38	3.03
Deferred Revenue	1.34	1.45	1.24	1.35	1.44	1.14
Current Debt	6.74	2.36	0.76	0.25	0.31	4.16
Other Current Liabilities	-0.68	-0.73	0.16	-0.63	-0.32	-0.11
Total Current Liabilities	10.27	6.37	4.19	4.16	4.81	8.22
Long-Term Debt	0.5	5.58	7.47	1.13	1.36	6.81
Other Long-Term Liabilities	0.76	0.79	0.76	0.88	1.08	0.65
Total Long-Term Liabilities	1.26	6.37	8.23	2	2.44	7.47
Total Liabilities	11.52	12.73	12.42	6.16	7.25	15.69
Total Debt	7.24	7.94	8.23	1.38	1.68	10.97
Debt Growth	-11.18%	-3.51%	497.68%	-17.84%	-84.72%	-8.23%
Retained Earnings	-224.13	-217.93	-189.36	-160.69	-129.99	-108.37
Comprehensive Income	17.24	12.03	16.84	4.75	4.57	7.37
Shareholders' Equity	45.86	31.18	52	80.62	97.35	14.37
Net Cash / Debt	33.94	18.27	38.29	65.78	82.24	3.83
Net Cash / Debt Growth	-2.56%	-52.28%	-41.79%	-20.02%	2047.74%	-79.56%
Working Capital	45.27	35.53	57.84	72.97	92.93	14.58
Book Value Per Share	2.15	1.46	2.49	3.88	4.96	1.21

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).